Stocks
AnaptysBio (ANAB) EBITDA US GAAP (year values) |
||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | |||
| EBITDA, bln rub | ? | -55.7 | -105.3 | -156.4 | -92.7 | 69.2 | 53.3 | |
| Changes by years, y/y, % | +188% | +89% | +49% | -41% | -175% | |||
AnaptysBio. EBITDA US GAAP, bln rub
AnaptysBio. EBITDA US GAAP, changes, %
AnaptysBio. EBITDA US GAAP, sum by quarters, bln rub
AnaptysBio (ANAB) EBITDA US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| EBITDA, bln rub | ? | -20.6 | -18.4 | 38.2 | 70.0 | -31.4 | 53.3 | |
| Changes by years, y/y, % | -44% | -48% | -327% | -1 940% | +52% | |||
| Changes by quarters, q/q, % | +442% | -11% | -308% | +83% | -145% | |||
